MGI has gone far and beyond the normal investor relationship - within the first quarter post investment they had set up 5 prospect meetings - they know what’s important to take businesses to the next level. Sujay Jadhav, CEO


Clinical study startup made easy.

MGI helps goBalto by opening doors to Japanese pharmaceutical companies and CROs.

Supported with : Healthcare SaaS investment experience
Supported with : Relationship with pharma execs

MGI has been value-added investor by bringing a diverse life science sector perspective, and has been strategically helpful and hands-on regarding business development in Japan. Ken Horne, co-founder & CEO


Symic Biomedical is developing a novel therapeutic platform focused on promoting and accelerating healing.

MGI is helping Symic Biomedical access global and Japanese pharmaceutical and medical device companies for potential co-development of their molecules.

Supported with : Relationship with pharma execs
Scientific expertise
Supported with : Business creation
Negotiation experience
© 2017 Mitsui & Co. Global Investment, Inc.